Carl Sterritt
Amministratore Delegato presso Phosphate Therapeutics Ltd.
Posizioni attive di Carl Sterritt
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Phosphate Therapeutics Ltd.
 Phosphate Therapeutics Ltd. BiotechnologyHealth Technology Phosphate Therapeutics Ltd. provides research and experimental development on biotechnology. It engages in development of drug named PT20 to cure high phosphate levels in blood. The company was founded in 2011 and is headquartered in Gateshead Quays, the United Kingdom. | Amministratore Delegato | - | - |
Storia della carriera di Carl Sterritt
Precedenti posizioni note di Carl Sterritt
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SHIELD THERAPEUTICS PLC | Direttore/Membro del Consiglio | 01/01/2008 | 22/04/2020 |
| Amministratore Delegato | 01/01/2008 | 22/04/2020 | |
| Fondatore | 01/01/2008 | 22/04/2020 | |
| UNITED THERAPEUTICS CORPORATION | Corporate Officer/Principal | - | - |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Corporate Officer/Principal | 01/01/2006 | - |
Shield Holdings AG
 Shield Holdings AG Pharmaceuticals: MajorHealth Technology Shield Holdings AG develops and commercializes late stage pharma products. The company was founded by Carl Sterritt and Christian Schweiger in 2008 and is headquartered in Wollerau, Switzerland. | Direttore/Membro del Consiglio | 02/06/2011 | 04/02/2015 |
| Amministratore Delegato | 02/06/2011 | - | |
| Presidente | - | - | |
| Fondatore | 01/01/2008 | - |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Regno Unito | 3 |
| Svizzera | 2 |
Posizioni
| Chief Executive Officer | 3 |
| Director/Board Member | 2 |
| Founder | 2 |
Settori
| Health Technology | 6 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| SHIELD THERAPEUTICS PLC | Health Technology |
| Aziende private | 3 |
|---|---|
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Health Technology |
Shield Holdings AG
Shield Holdings AG Pharmaceuticals: MajorHealth Technology Shield Holdings AG develops and commercializes late stage pharma products. The company was founded by Carl Sterritt and Christian Schweiger in 2008 and is headquartered in Wollerau, Switzerland. | Health Technology |
Phosphate Therapeutics Ltd.
Phosphate Therapeutics Ltd. BiotechnologyHealth Technology Phosphate Therapeutics Ltd. provides research and experimental development on biotechnology. It engages in development of drug named PT20 to cure high phosphate levels in blood. The company was founded in 2011 and is headquartered in Gateshead Quays, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Carl Sterritt
- Esperienza
